chrisvoncsefalvay/vaers-outcomes huggingface dataset:
drippy nose; She felt cold and chills but no fever; She felt cold and chills but no fever; lots of nasal congestion; chest congestion; productive cough; sinus infection; allergy symptoms; testing positive for Covid infection following administration for the first vaccine dose; testing positive for Covid infection following administration for the first vaccine dose; sore throat; This is a spontaneous report from a contactable nurse (patient).  A 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3302), via an unspecified route of administration in Deltoid Left on 19Jan2021 11:30 at single dose for COVID-19 immunization.  Medical history included Slightly elevated blood pressure from Feb2021 and ongoing, Elevated cholesterol from Feb2021 and ongoing.  Concomitant medication included pravastatin (PRAVASTATIN) from Feb2021 and ongoing for Elevated cholesterol, lisinopril (LISINOPRIL) from Feb2021 and ongoing for Slightly elevated blood pressure.  The patient experienced testing positive for covid infection following administration for the first vaccine dose on 04Feb2021. COVID: Initially reported onset of symptoms as 29Jan2021, but clarified onset of symptoms night of, or morning of 28Jan2021. She always had allergy symptoms like a drippy nose; she was getting ready to go get allergy testing in a few weeks; but on 28Jan2021 she noticed a real increase of sicker drainage all through the night. She thought she might had had a sinus infection. She felt cold and chills but no fever; she never had a fever; but had chills daily. She also had really bad sore throat that went away the next day; and lots of nasal congestion; chest congestion; productive cough. She still had nasal congestion and a little bit of chest congestion but chest congestion was very light in color. She had had no trouble breathing or shortness of breath; other than from her nose being stopped up. Seriousness criteria: Caller reported no emergency room visit, doctor's office visit or hospitalization related to this event. The patient underwent lab tests and procedures which included Flu test: unknown results on 03Feb2021, SARS-CoV-2 RT-PCR test: positive on 04Feb2021.  The outcome of event sore throat was recovered 1 day later on unspecified date, lots of nasal congestion was not recovered, while for other events was unknown.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 7 days after the second dose. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Unable to get out of bed; Brain fog; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Unable to get out of bed), FEELING ABNORMAL (Brain fog) and FATIGUE (Fatigue) in a 100-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Dec-2021, the patient experienced BEDRIDDEN (Unable to get out of bed), FEELING ABNORMAL (Brain fog) and FATIGUE (Fatigue). At the time of the report, BEDRIDDEN (Unable to get out of bed) and FATIGUE (Fatigue) had not resolved and FEELING ABNORMAL (Brain fog) outcome was unknown.            No concomitant product use was provided. No treatment medication was provided.
I26.99 ACUTE PULMONARY EMBOLISM 5/1/2023 ACUTE PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 5/1/2023 ACUTE PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 5/1/2023 ACUTE PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 5/1/2023 MODERATE COCAINE USE DISORDER
Throat started to close, became difficult to breath, face became warm, skin flushed. Throat continued to close for 10 minutes, received an epi pen injection
A little stiff; injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (A little stiff) and VACCINATION SITE SWELLING (injection site is swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (A little stiff) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, MUSCULOSKELETAL STIFFNESS (A little stiff) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took thyroid, cholesterol and antidepressant medication (unspecified).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Report received contains no significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Painful skin; Skin sensitivity on my upper back(left side), my left side, and my left breast; Miserable; This non-serious case was reported by a consumer via call center representative and described the occurrence of skin pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose received on an unknown date).   On 11-MAY-2023, the patient received the 2nd dose of Shingrix. In MAY-2023, an unknown time after receiving Shingrix, the patient experienced skin pain (Verbatim: Painful skin), sensitive skin (Verbatim: Skin sensitivity on my upper back(left side), my left side, and my left breast) and feeling miserable (Verbatim: Miserable). The outcome of the skin pain, sensitive skin and feeling miserable were not reported.   It was unknown if the reporter considered the skin pain, sensitive skin and feeling miserable to be related to Shingrix.     It was unknown if the company considered the skin pain, sensitive skin and feeling miserable to be related to Shingrix.   Additional Information: GSK receipt date: 15-May-2023 The patient received second dose of Shingrix on Thursday. The patient developed very painful skin and skin sensitivity on upper back left side and left breast. The patient feels miserable and wonder if he/she had Shingles.
Itching all over body, trouble breathing, asthma. Relieved with rescue inhaler and Benadryl.  2 episodes.
12-mo imm. Given 03-26-14; Developed fever 102.6 on 4/05/14; Reported increased sleep 5 hours during day. Rash to (rt) arm began 04-09-14. Seen 4-09-14 at office -> 30 mm x 17 mm raised erythematous plaque around injection site on (rt) tx: APAP/MOTRIN PRN (Recommend giving MMR and varicella at 4-5 yr vac, - separately.
About 30 minutes after the shot, i began to have an allergic reaction to the shot. Scratchy throat, minor breathing issue (like couldn't take a deep breath), itchy palms, head and feet. Off fire/tingle sensation in back of throat and tongue. I waited about an hour and a half and it was not getting better so I took one Benedryl pill and it resolved all issues.
fell; This is a spontaneous report. from a non-contactable consumer (reporter's uncle)  A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 05May2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient shortly thereafter fell on an unspecified date with outcome of unknown and was hospitalized. Caller would like to knowhow long he can go between shots or if he needs to start the series again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
School clinic. Pt. developed dizziness about 20 mins after h1n1 immunization.  Symptoms had lasted a few hours before presenting to MD's office.  Symptoms improved rapidly.
EXTREME debilitating fatigue 4 about 9 days.  Unsteady on feet, brain fog
Site: Pain at Injection Site-Mild, Systemic: Seizure-Medium, Additional Details: 5-10 minutes after vaccination, patient felt faint. When pharmacist walked over, patient had an absent stare, was unresponsive to questioning, and mild convulsions. Unresponsiveness lasted 30 seconds to a minute. Patient also lost control of urinary tract and relieved himself.
2days arm still hurts; Chills; Fever; Nausea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced chills (Verbatim: Chills), fever (Verbatim: Fever), nausea (Verbatim: Nausea) and pain in arm (Verbatim: 2days arm still hurts).  The outcome of the chills, fever and nausea were resolved (duration 2 days) and the outcome of the pain in arm was not resolved.   It was unknown if the reporter considered the chills, fever, nausea and pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the chills, fever, nausea and pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 17-SEP-2023 The case was received from the patient interactive digital media. The patient stated that same here chills, fever could not get warm nausea for 2 days arm still hurt. The patient had scary side effects if you ask him/her. The follow-up could not be possible as no contact details were available.
Complex febrile seizure (brief generalized tonic-clonic seizure activity within approx one hour while rapid rate of rise of fever eventually >40C).
Cold symptoms began weekend of 11/6 (congestion, cough). Negative Covid test 11/7. Symptoms improved over following week and then became substantially worse week of 11/14. Shortness of breath, productive cough. Diagnosed with bronchitis 11/22. As of 12/9 - one 5 day course of prednisone, improved SOB, additional 2-week course of prednisone prescribed when SOB returned. Albuterol + Symbicort also prescribed. SOB resolved at this time but minor cough still present.
Information has been received from a physician concerning a patient who on an unknown date, was vaccinated with a dose of PNEUMOVAX 23 (route and lot number not provided). On an unknown date, the patient experienced arthritis or arthralgia after receiving PNEUMOVAX 23. The patient's outcome was unknown at the time of reporting. It was unknown if the patient sought medical attention. Additional information is not expected.
Mom came back to facility on 1/14/11 with child and related the events that began after the immunizations received 1/11/11.  Mom states child ran a fever during the night after shots, no thermometer in home, Mom gave Ibuprofen and fever came down. During the day of 1/12/11 fever went up twice and brought down by Ibuprofen.  Mom states child also complained of headache and nausea.  Mom states legs were red and swollen at site of injections. Fever again on 1/13/11 and early in the morning of 1/14/11.  Mom states child to MD on 1/13/11 to follow-up on earwax and red eye problem-MD was aware of fever after vaccines but no fever at the MD appt and they were not concerned.  Child today temp is 96.8 by ear, no redness or swelling at injection sites, acting normally on visit playing with sticker, Mom states ate breakfast.  PHN again discussed side effects of vaccines, gave VIS's again.  Instructions to Mom to call MD if temp increases, headache gets worse or other symptoms increase.
Sudden chest pain last 15 minutes a, racing heart rate,and shortness of breath.
Patient reports that on October 5th, 2023 he received a flu vaccine in his left arm at 18101. He states that vaccine may have been slightly more painful than usual but nothing extreme. Since then, he has been experiencing "excruciating" pain and limited mobility on left side. He has tried ibuprofen with minimal relief. He went to his PCP and they stated that the shot may have been given too high. They ordered CT scan which was normal. He received a follow up MRI of left shoulder this morning and has appointment with an orthopedic group on Monday.
From about 4:00 p.m. until about 10:00 p.m., Patient had a headache, extreme chills, and a fever. From about 11:00 p.m. until 5:00 a.m., with varying intensity where she was able to sleep for an hour or so and then get woken up by the symptoms, she had at least a 103.5 degree fever, intense chills that caused her body to aggressively shake, excruciating pain throughout every part of her body that caused her to cry out in pain (she said it hurt more than anything she has ever felt), an intense migraine that was so bad it felt like her head was splitting open and her eyes torn out, shortness of breath and hyperventilating that caused her to repeatedly black out and weave in and out of consciousness, and extreme weakness to the point she could not move at all. She also said her muscles were aching and cramping and that her heart was pounding so hard it felt like it was hitting her rib cage. She wanted to call 911 because she didn't know how much longer she could hold on to consciousness, but was too weak to grab the phone, and her calls for help were weak and indecipherable. (Also, only her sister was home at the time, and she went to bed with earplugs in and couldn't hear patient.) From 5:00 a.m. to 7:00 a.m. many symptoms subsided, but there was still an agonizing pain in her kidneys (or adrenal glands?) that pulsed through her whole body. At 7:00 a.m. she woke up, and all the symptoms were gone, except for the area around her heart feeling strained. Two days later she called the nurse hotline and took ibuprofen as directed. The area around her heart gradually improved and seemed fine about two weeks later. Patient thinks she may have had Covid over a year ago because she remembers losing smell and having some chest pain that, for a couple of months, prevented her from exercising as she usually did. However, she never got tested because her symptoms were very mild. For her, getting Covid was a much better and less life-threatening experience than getting the Covid vaccine.
flu like symptoms; fever; fatigue; chillls; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever), FATIGUE (fatigue) and CHILLS (chillls) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included SIMVASTATIN, LEVOTHYROXINE SODIUM (LEVOTHYROXIN), GLUCOSAMINE, CURCUMA LONGA (TURMERIC CURCUMIN [CURCUMA LONGA]) and ZINC for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever), FATIGUE (fatigue) and CHILLS (chillls). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (fever), FATIGUE (fatigue) and CHILLS (chillls) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (Inconclusive) fever of 102 degrees.         The action taken for mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: Follow up information was received and contains no new information. On 28-May-2021: Follow up information was received and  patient demographics, concomitant medications, treatment  medications , new event were updated.
Information has been received from a consumer concerning her 73 year old husband with allergies to azithromycin and no medical histories, who on 13-JAN-2011 was vaccinated with a dose of ZOSTAVAX (therapy route and lot # not provided). Concomitant therapy included baby aspirin and lisinopril-HCTZ. On 10-FEB-2011 the patient broke out in hives across her back and chest. They had been treating the hives with CALAMINE LOTION and "CALADRYL" but they did not seem to be subsiding. The reporter stated that they initially thought that he broke out in shingles but she stated that their healthcare professional (HC) ruled shingles out based on a description of the rash. The HCP stated that he thought it was an allergic reaction to the vaccine. No lab diagnostics studies were performed. At the time of reporting, the patient's status was not provided. Patient sought unspecified medical attention and contacted the pharmacy to inquire. Follow-up information was expected received from the patient who reported that his doctor only suggested that ZOSTAVAX and did not instruct him to get it. Additional information is not expected.
I was exposed to COVID-19 in 4/27/23 and I tested positive for COVID-19 4/30/23. I had a dry cough, chills, fever, and fatigue. I contacted my doctor and was prescribed PAXLOVID. I am still dealing with this at this time.
was down for 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (was down for 3-4 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (was down for 3-4 days). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (was down for 3-4 days) outcome was unknown. Not Provided          No concomitant medications provided. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable, reporter didn't provide causality assessment.   This case was linked to US-MODERNATX, INC.-MOD-2021-089362 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089362:cross linked case
Patient developed nausea, dizziness, lightheadedness, tingling and contraction of hands within 5 minutes of receiving vaccine.  Resolved with po fluids only.
This spontaneous report as received from a medical assistant refers to a currently 5 year old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient ws vaccinated with a dose of VARIVAX (Merck) lot # J012210, expiry 28-SEP-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Muscle/body aches, headache, fever - Tylenol 1000mg PO given twice 10 hours apart. Woke up 24 hours post first symptom with only slightly achy injection site.
After my second dose of Moderna I began to experience changes in my menstrual cycle.  Due to previously being on the birth control pill, my menstrual cycle was virtually non-existent and just very light flow over 1-2 days and no cramping.  Since the second vaccine my menstrual cycle has become considerably heavier, longer and more painful.
Left arm neuropathy.  Patient has pain and decreased strength in left arm.  Pain and weakness started immediately after injection.  Patient is now having pain into her neck and down her left arm.
Mild body aches, mild headache, fatigue. Started next day about 20 to 21 hours after vaccinated. Next morning felt fine .
At approximately 1605, patient reported feeling nauseous in vaccination chair. Patient vomited in emesis bag. Patient reported feeling anxious before vaccination and a history of anxiety and panic attacks. Patient reported vomiting after receiving an unspecified vaccine in 2019. Patient offered anti-gravity chair. Patient refused anti-gravity chair. Patient denied difficulty breathing, difficulty swallowing, itchiness, rashes and hives. Patient advised to wait for further observation. Patient given water. At 1615, EMT  assessed patient vital signs: blood pressure 136/88 mmHg and pulse 115 beats/minute. At 1621, EMT reassessed patient vital signs: blood pressure 130/80 mm Hg and pulse 78 beats/minute. At 1633, EMT  reassessed patient vitals: blood pressure 112/76 mmHg and pulse 74 beats/minute. At 1635,  lead nurse assessed patient. Patient denied feeling nauseous. Patient stated "I feel okay". Lead nurse educated patient on signs/symptom of when to seek emergency care, to sign up on v-safe, and to follow up with primary care provider. At approximately 1640, patient left facility with unlabored respirations and steady gait.
Pfizer Dose 1 2/19/21 9EN6200) Pfizer Dose 2 3/13/21 (EN6204) Pfizer Does 3 1/26/22 (33030BD) COVID Positive 3/27/22  3/27/22: Patient has significant history of cognitive deficits multiple medical problems and tested positive for COVID in the ER.  Patient has an oxygen demand and is a good candidate at this time from the severe protocol. Patient is not short of breath and is not in any respiratory distress.  3/29/22: Patient was admitted with Covid 19. She had been found on the floor at her home by family, and had a low grade fever and complained of dyspnea at that time. She was admitted for IV Remdesivir treatment. Patient has not required oxygen at all since admission, she has no respiratory symptoms, has been afebrile, is eating well, and wants to be released today. She has been fully immunized against Covid prior to this illness, and her symptoms seem to have completely resolved at this point, so she will be discharged home.
Initial misuse report received from a healthcare professional on 11 November 2013. On unspecified date a 28-months-old male patient received second dose of FLUZONE earlier that what should have been scheduled date. Should have been administered one month after the first dose but was given 21 days after dose first dose. It's an inappropriate schedule of vaccine administered. No adverse event was reported. List of documents held by sender: none.
Patient came in with rash on abdomen one sided had received vaccine several days ago - told her to see Dr. at walk in clinic. On Sat. - shingles - Dr. started her on acyclovir ZOSTAVAX prescribed by one Dr. pt treated by another Dr.
Since vaccine was administered, pt has had muscle soreness originating from site of injection. Pt reports limited ROM without soreness, pain and limited strength. Pain occasionally radiates to forearm, numbness, and tingling in all fingers (rt arm). Appt with physican office on 03/25/2002.